Results 101 to 110 of about 129,296 (209)

NADK is activated by oncogenic signaling to sustain pancreatic ductal adenocarcinoma. Schild et al.

, 2021
Tanya Schild
openalex   +1 more source

Absence of an embryonic stem cell DNA methylation signature in human cancer. [PDF]

, 2019
BackgroundDifferentiated cells that arise from stem cells in early development contain DNA methylation features that provide a memory trace of their fetal cell origin (FCO). The FCO signature was developed to estimate the proportion of cells in a mixture
Christensen, Brock C, Kelsey, Karl T, Koestler, Devin C, Salas, Lucas A, Wiencke, John K, Zhang, Ze   +5 more
core  

Systematic review of peri-operative prognostic biomarkers in pancreatic ductal adenocarcinoma [PDF]

, 2016
Wilson Petrushnko, Justin S. Gundara, Philip R. de Reuver, Greg O’Grady, Jaswinder S. Samra, Anubhav Mittal   +5 more
openalex   +1 more source

A novel risk-scoring system conducing to chemotherapy decision for patients with pancreatic ductal adenocarcinoma after pancreatectomy [PDF]

, 2021
Yuqiang Li, Mengxiang Tian, Yuan Zhou, Fengbo Tan, Wenxue Liu, Lilan Zhao, Daniel Pérez, Xiangping Song, Dan Wang, Christine Nitschke, Qian Pei, Cenap Güngör   +11 more
openalex   +1 more source

Comprehensive transcriptomic analysis of cell lines as models of primary tumors across 22 tumor types. [PDF]

, 2019
Cancer cell lines are a cornerstone of cancer research but previous studies have shown that not all cell lines are equal in their ability to model primary tumors.
Aran, D, Butte, AJ, Charalel, J, Chen, B, Goldstein, T, Sirota, M, van 't Veer, LJ, Wolf, DM, Yau, C, Yu, K   +9 more
core   +1 more source

Pancreatic ductal adenocarcinoma

, 2017
Henry Knipe
openalex   +1 more source

Digital quantitative tissue image analysis of hypoxia in resected pancreatic ductal adenocarcinomas

, 2022
Iram Siddiqui, Jade Bilkey, Trevor D. McKee, Stefano Serra, Melania Pintilie, Trevor Do, Jing Xu, Ming‐Sound Tsao, Steve Gallinger, Rićhard P. Hill, David W. Hedley, Neesha C. Dhani   +11 more
openalex   +1 more source

Molecular Magnetic Resonance Imaging of Dysregulated Zinc Secretion Detects Early Pancreatic Ductal Adenocarcinoma Lesions and Response to KRASG12D Inhibitor Treatment [PDF]

Veronica Clavijo Jordan, Mozhdeh Sojoodi, Farzad Moloudi, Patricia Gonzalez Pagan, Manyu Jin, Pamela Pantazopoulos, Ethan French, Jonah Weigand‐Whittier, Nicholas J. Rotile, Mehrad Tavallai, Jill Hallin, Ian Ramsay, Eric M. Gale, Stephen Barrett, Nabeel Bardeesy, Motaz Qadan, Kenneth K. Tanabe, Peter Caravan   +17 more
openalex   +1 more source

Outcomes of Distal Pancreatectomy for Pancreatic Ductal Adenocarcinoma in the Netherlands: A Nationwide Retrospective Analysis [PDF]

, 2015
Thijs de Rooij, Johanna A.M.G. Tol, Casper H.J. van Eijck, Djamila Boerma, Bert A. Bonsing, Koop Bosscha, Ronald M. van Dam, Marcel G. W. Dijkgraaf, Michael F. Gerhards, Harry van Goor, Erwin van der Harst, Ignace H. J. T. de Hingh, Geert Kazemier, Joost M. Klaase, I. Quintus Molenaar, Gijs A. Patijn, Hjalmar C. van Santvoort, Joris J. Scheepers, George P. van der Schelling, Egbert Sieders, Olivier R. Busch, Marc G. Besselink, Marc G. Besselink   +22 more
openalex   +1 more source

Exosomal delivery of CRISPR/Cas9 complexes for targeted editing of KRAS^G12D in pancreatic cancer: prerequisites for clinical surgical application

Український журнал клінічної хірургії
Objective. To evaluate exosomes obtained from patients with ductal adenocarcinoma of the pancreas as carriers of CRISPR/Cas9 complexes for targeted editing of KRAS^G12D in pancreatic cancer and to test their stability, editing efficiency, and ...
S. M. Gramatyuk, Yu. V. Ivanova, I. M. Mamontov, I. A. Kryvoruchko, E. Hubbard, K. Sargsyan   +5 more
doaj   +1 more source